The therapeutic use of fractionated subtotal body irradiation.
A technique is presented for the treatment of generalized radiosensitive malignancies. The results of fractionated STBI (subtotal body irradiation) in a group of 41 patients are at least as satisfactory as those achieved by any other therapeutic modality. Eight of 9 patients with generalized Stage III and IV nodular lymphocytic lymphoma, both well and poorly differentiated, are living without evidence of disease, from 15 to 82 months since treatment.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000532:radiotherapy; D003863:Depression / Q000209:etiology; D004407:Dysgerminoma / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D006689:Hodgkin Disease / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000532:radiotherapy; D008223:Lymphoma / Q000473:pathology / Q000532:radiotherapy*; D008297:Male; D008722:Methods; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010997:Pleural Neoplasms / Q000473:pathology / Q000532:radiotherapy; D011879:Radiotherapy Dosage